Evaluation of protective immunity responses against pneumococcal PhtD and its C-terminal in combination with

Mohammadali Malekan1, Seyed Davar Siadat2,3, Mohammadreza Aghasadeghi4

  • 1Department of Microbiology, Pasteur Institute of Iran, Tehran, Iran.

Insights

Polyhistidine triad protein D (PhtD) and its fragment PhtD-C were tested as pneumococcal vaccine candidates. Combinations with alum and outer-membrane vesicles (OMVs) showed promising immune responses and survival rates in mice.

Area of Science:

  • Vaccinology
  • Microbiology
  • Immunology

Background:

  • Streptococcus pneumoniae is a major human bacterial pathogen.
  • Existing pneumococcal vaccines have limitations.
  • Serotype-independent pneumococcal proteins are desirable vaccine candidates.

Purpose of the Study:

  • To evaluate recombinant polyhistidine triad protein D (PhtD) and its C-terminal fragment (PhtD-C) as pneumococcal vaccine candidates.
  • To assess the immunogenicity and efficacy of PhtD and PhtD-C when formulated with alum and outer-membrane vesicles (OMVs) as adjuvants.

Main Methods:

  • Recombinant PhtD and PhtD-C were prepared.
  • Mice were immunized with PhtD/PhtD-C combined with alum or OMVs.
  • Humoral immune responses (total IgG, specific IgG, IgG1, IgG2a) were measured.
  • Serum bactericidal assays and opsonophagocytosis tests were conducted.
  • Survival rates after pneumococcal challenge were assessed.

Main Results:

  • Specific IgG and IgG1 levels increased significantly after PhtD/PhtD-C immunization with alum or OMVs.
  • Opsonophagocytosis and serum bactericidal assays demonstrated significant killing of Streptococcus pneumoniae.
  • Mice immunized with PhtD/PhtD-C plus alum or OMVs showed increased survival rates post-challenge.

Conclusions:

  • PhtD and PhtD-C, particularly with alum adjuvant, elicit robust immune responses against Streptococcus pneumoniae.
  • The combination of PhtD/PhtD-C with alum demonstrated optimal results compared to OMVs.
  • These findings support the potential of PhtD-based vaccines for preventing pneumococcal infections.